Skip to main content
Fig. 2 | Cardiovascular Diabetology

Fig. 2

From: Dapagliflozin improves myocardial flow reserve in patients with type 2 diabetes: the DAPAHEART Trial: a preliminary report

Fig. 2

Myocardial perfusion: Myocardial flow reserve (A); resting myocardial blood flow (MBF) corrected for rate pressure product (B); stress myocardial blood flow (C); Data are mean ± SEM; **p < 0.01. Myocardial perfusion PET images of two representative cases: regional and global myocardial blood flow (MBF) and myocardial flow reserve (MFR) quantification at rest and during adenosine stress pre- and post-placebo (D) and pre- and post-dapagliflozin (E), respectively

Back to article page